Nurse Practitioner in Morrill, ME Accepting Medicare
1 Nurse Practitioner nurses found. Showing 1 - 1
 Kathleen Truslow, N.P Nurse Practitioner - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 29 Weymouth Rd, Morrill, ME 04952 Phone: 207-878-0094 Fax: 207-878-0096 |
News Archive
Patient enrollment for Phase 2b study of PRX302 completed by Protox Therapeutics
Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today announced that it has completed patient enrollment in its multi-centre, double-blinded, placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in males with moderate to severe benign prostatic hyperplasia (BPH), a common and bothersome urological condition that affects more than 50 million men worldwide.
Some House GOP lawmakers take hard line position against health law funding in debt limit debate
As Republican leaders unveiled a plan to avert a government shutdown, they faced the challenge of building support for the proposal within their own ranks because it does not defund the health law. Some within the caucus reacted with skepticism.
Addressing multiple unhealthy behaviors at once may be more effective than sequential approach
Physicians trying to help patients change more than one behavioral risk factor may have more success approaching several topics at once rather than addressing them separately over time, according to a report in the June 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Nurses face increased likelihood of burnout during COVID-19, reports study
Early in the COVID-19 pandemic, more than 40 percent of nurses and other health care workers had risks associated with an increased likelihood of burnout, reports a survey study in the August issue of the American Journal of Nursing.
Seaside Therapeutics granted U.S patent covering methods of treating autism
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
› Verified 7 days ago